No abstract available
Keywords:
Donor cells; MDS; Ring chromosome 7.
MeSH terms
-
Allografts
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal, Murine-Derived / administration & dosage
-
Biomarkers, Tumor
-
Bone Marrow / pathology
-
Cell Transformation, Neoplastic / genetics*
-
Chromosome Deletion*
-
Chromosomes, Human, Pair 7 / genetics
-
Chromosomes, Human, Pair 7 / ultrastructure*
-
Cyclophosphamide / administration & dosage
-
Disease Progression
-
Female
-
Gene Deletion*
-
Humans
-
In Situ Hybridization, Fluorescence
-
Leukemia, Myeloid, Acute / etiology*
-
Leukemia, Myeloid, Acute / genetics
-
Leukemia, Myeloid, Acute / pathology
-
Living Donors
-
Lymphoma, Follicular / drug therapy
-
Lymphoma, Follicular / therapy*
-
Lymphoma, Mantle-Cell / drug therapy
-
Lymphoma, Mantle-Cell / therapy*
-
Male
-
Middle Aged
-
Myelodysplastic Syndromes / etiology*
-
Myelodysplastic Syndromes / genetics
-
Myelodysplastic Syndromes / pathology
-
Neoplasms, Second Primary / etiology*
-
Neoplasms, Second Primary / pathology
-
Peripheral Blood Stem Cell Transplantation*
-
Proto-Oncogene Proteins c-ets / deficiency
-
Proto-Oncogene Proteins c-ets / genetics
-
Repressor Proteins / deficiency
-
Repressor Proteins / genetics
-
Ring Chromosomes*
-
Rituximab
-
Transplantation Chimera / genetics
-
Vidarabine / administration & dosage
-
Vidarabine / analogs & derivatives
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Murine-Derived
-
Biomarkers, Tumor
-
ETS translocation variant 6 protein
-
Proto-Oncogene Proteins c-ets
-
Repressor Proteins
-
Rituximab
-
ibritumomab tiuxetan
-
Cyclophosphamide
-
Vidarabine
-
fludarabine